Rapport Therapeutics, Inc. Common Stock (RAPP)
18.83
(-1.26%)
18.83
(-1.26%)
| Breakdown | 2023 | 2022 |
|---|---|---|
| Operating Cash Flow | -27.18 Million | -3.24 Million |
| Net Income | -34.78 Million | -10.65 Million |
| Depreciation & Amortization | 112 Thousand | 15 Thousand |
| Deferred income taxes | - | - |
| Stock-based compensation | 3.52 Million | - |
| Change in working capital | 2.65 Million | 1.48 Million |
| Other non-cash items | 5.06 Million | 5.93 Million |
| Investing Cash Flow | -78.86 Million | -5.28 Million |
| Investments in PPE | -1.63 Million | -284 Thousand |
| Acquisitions | - | - |
| Investment purchases | -77.22 Million | - |
| Sales/Maturities of investments | - | - |
| Other Investing Activities | - | -5 Million |
| Financing Cash Flow | 145.13 Million | 39.68 Million |
| Debt repayment | - | -7.89 Million |
| Dividends payments | - | - |
| Common Stock Repurchased | -4000.00 | - |
| Common Stock Issuance | 145.27 Million | 31.78 Million |
| Other Financing Activities | -134 Thousand | - |
| Accounts receivables | - | - |
| Accounts payables | 856 Thousand | - |
| Inventory | - | - |
| Other working capital | 2.65 Million | 1.48 Million |
| Cash at beginning of period | 31.15 Million | - |
| Cash at end of period | 70.25 Million | 31.15 Million |
| Capital Expenditure | -1.63 Million | -284 Thousand |
| Effect of forex changes on cash | - | - |
| Net cash flow / Change in cash | 39.09 Million | 31.15 Million |
| Free Cash Flow | -28.81 Million | -3.52 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.12 Million | -22.66 Million | -34.78 Million | -6.41 Million | -6.14 Million | -10.65 Million |
| Depreciation & Amortization | 208 Thousand | 152 Thousand | 112 Thousand | 21 Thousand | 15 Thousand | 15 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.35 Million | 1.49 Million | 3.52 Million | 945 Thousand | 723 Thousand | - |
| Change in working capital | -123 Thousand | -3.15 Million | 2.65 Million | -1.15 Million | -422 Thousand | 1.48 Million |
| Other non-cash items | 2.1 Million | 8.36 Million | 5.06 Million | 987 Thousand | 1.78 Million | 5.93 Million |
| Investing Cash Flow | -107.1 Million | -41.92 Million | -78.86 Million | -86 Thousand | -61 Thousand | -5.28 Million |
| Investments in PPE | -967 Thousand | -1.07 Million | -1.63 Million | -86 Thousand | -61 Thousand | -284 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -138.43 Million | -44.8 Million | -77.22 Million | - | - | - |
| Sales/Maturities of investments | 32.29 Million | 3.94 Million | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -5 Million |
| Financing Cash Flow | 159.35 Million | 63.65 Million | 145.13 Million | -90 Thousand | 60 Million | 39.68 Million |
| Debt repayment | - | - | - | - | - | -7.89 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -4000.00 | - | - | - |
| Common Stock Issuance | 159.07 Million | 63.94 Million | 145.27 Million | -50 Thousand | 60.02 Million | 31.78 Million |
| Other Financing Activities | 283 Thousand | -283 Thousand | -134 Thousand | -40 Thousand | -18 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 94 Thousand | -1.13 Million | 856 Thousand | -48 Thousand | -454 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -123 Thousand | -3.15 Million | 2.65 Million | -1.15 Million | -422 Thousand | 1.48 Million |
| Cash at beginning of period | 74.37 Million | 70.25 Million | 31.15 Million | 86.3 Million | 31.15 Million | - |
| Cash at end of period | 110.26 Million | 74.37 Million | 70.25 Million | 79.52 Million | 86.3 Million | 31.15 Million |
| Capital Expenditure | -967 Thousand | -1.07 Million | -1.63 Million | -86 Thousand | -61 Thousand | -284 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 35.89 Million | 4.11 Million | 39.09 Million | -6.77 Million | 55.14 Million | 31.15 Million |
| Free Cash Flow | -17.31 Million | -18.68 Million | -28.81 Million | -6.68 Million | -4.86 Million | -3.52 Million |
TAR
ARDS
SCHW-PJ
3472
FMCCS
SEER